Breast Mesh Lawsuit Overview

Over the past decade, surgical mesh implants have become increasingly common in breast reconstruction and cosmetic augmentation procedures. Marketed as soft tissue repair devices, surgeons have used these mesh products as scaffolding in so-called “internal bra” procedures to provide additional support beneath the breast and help maintain implant position and shape.

However, breast mesh lawsuits will allege that manufacturers failed to disclose the risks associated with using mesh in breast surgeries, and negligently sold their products for unapproved, off-label purposes. The U.S. Food and Drug Administration (FDA) has confirmed that no surgical mesh has ever been approved as safe and effective for breast reconstruction or augmentation, yet the devices were widely adopted in the medical community.

Many women have since reported serious complications, including infections, chronic pain, mesh migration, and reconstruction failure. Breast mesh injury lawyers are now investigating whether the manufacturers misrepresented the safety of these products and ignored mounting evidence of harm linked to their off-label use in breast surgeries.

Who Is Eligible for a Breast Mesh Lawsuit?

Financial compensation may be available through a breast mesh lawsuit settlement for individuals who underwent breast reconstruction, augmentation, or revision surgery that involved the use of a mesh implant and subsequently developed serious complications, including:

• Infection or abscess formation, including cases requiring antibiotics, hospitalization, or surgical removal
• Chronic pain or nerve damage around the chest, breast, or underarm area
• Seroma (persistent fluid buildup or swelling beneath the breast)
• Capsular contracture, in which scar tissue tightens painfully around the implant
• Mesh migration or displacement, leading to asymmetry, breast distortion, or loss of implant support
• Implant rupture or reconstructive failure requiring removal or replacement
• Interference with breast imaging, including mammogram or ultrasound detection issues
• Permanent scarring or disfigurement following mesh removal
• Removal, replacement, or revision surgery due to mesh-related complications or failure

These lawsuits seek compensation for medical expenses, pain and suffering, lost income, and other financial losses caused by breast mesh complications.

2026 Breast Mesh Lawsuit Updates

• March 5, 2026 Update: Reports of complications following internal bra breast mesh procedures are raising new questions about whether manufacturers adequately disclosed the potential risks associated with these implants. Women across the U.S. have described infections, chronic inflammation, fluid buildup and implant instability that sometimes require revision surgery or removal of the mesh. As a result, product liability investigations are now reviewing whether manufacturers failed to warn patients and surgeons about the likelihood of these complications when marketing breast mesh as a long-term support solution.
• December 11, 2025 Update: Several plastic surgeons have issued internal-bra warnings cautioning that mesh products used in breast lifts and augmentations may offer little proven benefit while exposing patients to serious risks, including infection, inflammation, deformity and failed reconstruction. These public surgeon warnings are fueling new breast mesh lawsuit investigations, as women allege manufacturers aggressively marketed mesh for cosmetic use despite a lack of FDA approval or reliable long-term safety data.
• November 14, 2025 Update: A former Becton Dickinson medical director is warning that GalaFLEX mesh is being used off-label in breast reconstruction without evidence that it is safe or effective. He says the material may cause complications and could even interfere with detecting recurrent breast cancer. His statements have led to growing interest in breast mesh lawsuits involving women who experienced injuries after implantation.
• November 10, 2025 Update: Breast mesh use continues to surge in reconstruction and cosmetic surgery, even though no mesh product has been approved by the FDA for use in breast tissue. Studies and FDA warnings highlight higher risks of infection, implant failure, and revision surgery, raising new safety concerns as sales grow. These issues are driving more women to investigate breast mesh lawsuits over off-label marketing and device complications.

How Internal Bra Mesh Products Work

Internal bra mesh products have been used to provide internal support and stability during breast reconstruction, augmentation, or revision surgeries. While these devices were intended to strengthen weakened tissue, improve breast shape, and prevent implants from shifting or sagging over time, many women have been left with devastating internal bra side effects.

Unlike traditional breast lifts that rely only on skin tightening, internal bra surgery uses a layer of mesh material inside the breast to create a permanent or semi-permanent foundation. The mesh acts as an internal sling or hammock, supporting the lower pole of the breast and reinforcing soft tissue, where it may be too thin or weak to hold an implant securely.

In breast reconstruction after mastectomy, surgeons use mesh to replace or strengthen tissue removed during cancer surgery, or to rebuild the breast pocket for an implant or tissue expander. The same mesh materials are also used in revision surgeries to correct issues such as implant bottoming out, asymmetry, or loss of shape from prior procedures.

These products are typically made from either synthetic absorbable polymers, such as poly-4-hydroxybutyrate (P4HB), or biologic materials derived from processed human or animal tissue. They are marketed under names like “bioresorbable scaffold” or “tissue matrix,” and are designed to either dissolve gradually or integrate with the surrounding tissue over time.

While the idea behind breast mesh support is to improve results and longevity, these devices were never approved by the FDA for use in breast surgery. Despite their increasing popularity, reports of mesh breakdown, loss of support, and reconstruction failure continue to be reported among recipients.

Why Internal Bra Mesh Fails

Internal bra mesh has been used in an effort to reinforce tissue and support breast implants, but reports have raised concerns about how some products perform once implanted. Mesh materials originally cleared for hernia repair or general soft tissue reinforcement were later used in the breast, a setting with different movement and tissue characteristics, where some reports suggest the materials may not perform as intended.

Over time, several patterns of breast mesh failure have been reported:

• Premature degradation: Absorbable meshes, like those made from P4HB polymers, can dissolve too quickly, leaving the implant unsupported before healing is complete.
• Loss of tensile strength: Mesh fibers can stiffen, stretch, or weaken under constant strain, causing the material to lose its intended shape.
• Poor tissue integration: If the mesh fails to incorporate into the surrounding tissue, it can detach from the implant pocket or fold on itself, leading to uneven support.
• Inflammatory breakdown: The body may recognize mesh fibers as foreign material, triggering inflammation that erodes tissue and interferes with healing.
• Mechanical stress and fatigue: Daily motion, exercise, or muscle contraction from the chest wall can cause repetitive strain, pulling the mesh away from fixation points.

These mechanical and biological failures often start gradually but can compromise the breast’s shape and support over time. When the mesh no longer holds its position, the implant can shift, the reconstruction can collapse, or scar tissue can form around distorted mesh fibers, making corrective surgery difficult.

While marketed as innovative or absorbable scaffolds, internal bra meshes were never approved to endure the long-term mechanical stress of the breast, raising serious concerns about their durability and safety.

Internal Bra Failure Revision Surgery

When an internal bra mesh begins to fail, many women eventually require revision surgery to remove the material, reposition implants, or rebuild the breast pocket. The timing and approach depend on the type of mesh used, how the body has reacted to it, and the extent of tissue damage caused by the implant’s movement or breakdown.

Revision procedures are often complex because the mesh is partially absorbed or fused with surrounding tissue. In some cases, surgeons must dissect scar tissue and remove remaining mesh fragments, which can increase bleeding risk and prolong healing. For biologic or synthetic meshes that have degraded unevenly, removal can leave irregular tissue planes or thin skin coverage, requiring additional reconstructive techniques.

After removal, the surgeon may:

• Replace the implant with a smaller or differently shaped device to restore symmetry.
• Reinforce the pocket with new tissue flaps or fat grafting instead of another mesh.
• Perform a breast lift or capsulectomy to reshape tissue and remove hardened scar tissue (capsular contracture).
• Delay reconstruction to allow inflammation or infection to resolve before further procedures.

Recovery from revision surgery can take several months and may require staged operations to achieve the desired cosmetic result. In cases of infection, the mesh and implant are typically removed together, and reconstruction is postponed until the tissue fully heals.

Women who have undergone revision procedures often report loss of sensation, persistent pain, or visible scarring due to the invasive nature of mesh removal. For many, these secondary surgeries are physically and emotionally draining — especially when the original “internal bra” procedure was marketed as a permanent solution that would improve long-term support and appearance.

Internal Bra Failure Side Effects

Adverse event reports submitted to the FDA through its MAUDE database describe a range of complications reported by women following internal bra mesh procedures. According to these reports, problems may develop gradually over time and, in some cases, have required additional surgeries to remove mesh, revise implants, or address damage to surrounding tissue.

Reported complications associated with internal bra mesh failure include:

• Infection and abscess formation: MAUDE reports describe infections that allegedly developed around breast mesh implants, sometimes months after surgery. These reports often reference pain, swelling, redness, drainage, or abscess formation, with some patients requiring surgical removal of the mesh and implant to address persistent infection.
• Seroma and fluid buildup: Some adverse event reports note fluid accumulation around the implant site following mesh implantation. Women reported swelling, pressure, and discomfort, with certain cases involving repeated drainage procedures or ongoing inflammation.
• Capsular contracture: FDA reports include accounts of excessive scar tissue forming around breast implants following mesh use. In these cases, women described breast hardening, pain, and visible distortion, sometimes leading to revision surgery.
• Mesh migration or detachment: MAUDE submissions also describe instances where mesh allegedly shifted, detached, or failed to remain in place. These reports often involve loss of implant support, breast asymmetry, or a “bottoming out” appearance that required corrective procedures.
• Implant rupture and reconstructive failure: Some reports link loss of mesh support to implant failure, including rupture or collapse. In reconstructive patients, adverse events sometimes resulted in the need for multiple revision surgeries and long-term cosmetic changes.
• Nerve damage and chronic pain: Women submitting FDA reports have described ongoing pain, burning sensations, or numbness in the breast or underarm area following mesh implantation. In some cases, symptoms reportedly continued even after mesh removal.
• Skin erosion and tissue necrosis: MAUDE reports include allegations of skin thinning, tissue breakdown, or mesh exposure through the skin. These complications frequently required implant removal and additional reconstructive treatment.
• Breast distortion and asymmetry: According to adverse event reports, mesh failure has been associated with visible changes in breast shape or alignment, including drooping, dimpling, or uneven appearance, particularly when only one breast was affected.
• Interference with mammograms and breast imaging: Some women reported that mesh placement or scarring interfered with mammograms or other breast imaging, potentially complicating routine screening or follow-up evaluations.
• Inflammation and autoimmune response: A limited number of reports describe broader inflammatory symptoms following mesh implantation, including fatigue or joint pain.

While reported side effects vary in severity, MAUDE submissions frequently describe the need for revision or removal surgeries after internal bra mesh complications. Many women report undergoing multiple procedures in an effort to address pain, cosmetic changes, or ongoing tissue damage.

Breast Mesh Products Linked to Complications

A growing number of breast mesh and internal bra products have been associated with painful complications and reconstructive failures after surgery. These devices were sold to plastic surgeons as supportive scaffolds, which women were told would help keep the implants in place, improve shape, and strengthen weakened tissue.

However, none of these mesh materials have been approved by the U.S. Food and Drug Administration (FDA) for use in breast surgery, and many were originally cleared for hernia or general soft-tissue repair through the FDA’s 510(k) process. The off-label use of these devices has led to reports of infection, capsular contracture, mesh breakdown, and revision surgeries among women who underwent breast reconstruction or cosmetic augmentation.

Who Is the Breast Mesh Lawsuit Being Investigated Against?

Lawyers are currently investigating potential breast mesh lawsuits against several medical device manufacturers that designed, produced, and sold surgical mesh products that were used for off-label purposes in breast reconstruction and cosmetic augmentation procedures.

Attorneys are reviewing whether these companies failed to warn about the risks of mesh degradation, infection, and reconstructive failure.

Potential claims are being reviewed against the following manufacturers and product lines:

• Becton Dickinson & Company (BD): Manufacturer of the GalaFLEX, GalaFORM, and GalaSHAPE mesh scaffolds through its Galatea Surgical subsidiary, and producer of Phasix and Phasix ST mesh through its C.R. Bard division.
• Integra LifeSciences Corporation: Developer of DuraSorb Monofilament Mesh and SurgiMend biologic mesh, both used off-label in breast reconstruction and revision surgeries.
• Allergan / LifeCell Corporation: Makers of AlloDerm and Strattice biologic meshes, derived from human and porcine tissue, which have been widely used in post-mastectomy reconstruction procedures.
• Ethicon, Inc. (a subsidiary of Johnson & Johnson): Distributor of FlexHD biologic mesh, identified by the FDA in 2021 as having higher rates of infection and implant removal following breast reconstruction.

Investigations focus on whether these companies marketed or allowed their products to be used in unapproved breast surgeries without conducting appropriate safety testing or disclosing the risks of tissue damage, implant failure, and recurrent inflammation.

What Are Breast Mesh Lawsuits Expected to Allege?

While no lawsuits have been filed yet, attorneys reviewing potential claims anticipate that breast mesh lawsuits will raise similar allegations to those seen in prior hernia and vaginal mesh litigations. These include:

• Off-label promotion: Manufacturers allegedly encouraged or failed to prevent their products from being used in breast surgeries, even though they were not cleared or approved for those indications.
• Failure to warn: The companies are accused of omitting key information about the risks of infection, scarring, and premature mesh breakdown.
• Defective design: The materials may degrade too quickly, harden, or detach, leading to loss of implant support and reconstruction failure.
• Negligent misrepresentation: Surgeons and patients were allegedly led to believe that these meshes would provide lasting support when long-term safety data did not exist.
• Concealment of adverse events: Plaintiffs may argue that manufacturers ignored or downplayed reports of complications and continued marketing these devices for breast use.

These claims are being investigated nationwide to determine whether women who received these mesh implants have experienced similar patterns of complications.

Is There An Internal Bra Class Action Lawsuit?

At this time, no breast mesh class action lawsuit has been filed, nor has a formal multidistrict litigation (MDL) to coordinated proceedings for internal bra claims been established. Attorneys across the United States are in the early stages of identifying potential plaintiffs and evaluating injury reports.

Several different manufacturers are involved in the sale of breast mesh products, and many of the same materials have been marketed under multiple brand names. The investigation phase is critical to determining how widespread these issues may be and which products share the same design or material defects. If a substantial number of women come forward, attorneys are expected to seek consolidation of the claims in federal court to coordinate pretrial proceedings and ensure consistent rulings.

This approach is similar to the process used in prior mesh litigations, including those involving hernia mesh and transvaginal mesh devices, which led to settlements after early trials revealed consistent design and safety problems.

Internal Bra Mesh Lawsuit Settlements

Women who underwent breast reconstruction or augmentation with mesh implants that later failed may be entitled to financial compensation. Potential damages could include:

• Medical expenses for implant removal, revision, or reconstructive surgeries
• Hospitalization and follow-up treatment costs
• Lost income or reduced earning capacity
• Pain and suffering associated with chronic pain, infection, or nerve damage
• Emotional distress and diminished quality of life
• Permanent scarring, asymmetry, or disfigurement

Potential Breast Mesh Settlement Amounts

Since claims remain in the early investigative stages, there are currently no settlements or court awards related to breast mesh injuries. However, the potential value of these claims will likely depend on the severity of complications and the extent of corrective surgeries required.

Based on similar mesh litigations, future settlement amounts could be influenced by:

• The type of mesh material implanted
• Whether multiple revision or removal surgeries were required
• The degree of scarring or permanent disfigurement
• Long-term complications such as nerve damage or infection
• Economic losses, including medical bills and lost income

While the value of any potential breast mesh lawsuit will depend on the facts of the case, previous mass tort mesh settlements, such as those involving pelvic and hernia mesh products, have ranged between $50,000 and over $1 million per plaintiff, depending on the severity of injuries and strength of the evidence.

How Long Do I Have to File a Breast Mesh Lawsuit?

Every state has its own statute of limitations, which limits how long a person has to file a product liability lawsuit. In most jurisdictions, the filing deadline ranges from one to three years after an individual discovers, or should have discovered, that their injury was caused by a medical device.

The deadline may vary based on several factors, including:

• The date of the initial breast reconstruction or augmentation procedure
• When complications such as infection, pain, or mesh failure were first diagnosed
• When the mesh was surgically removed or revised
• Whether the claim involves product liability or medical malpractice

Since these deadlines differ from state to state, women who believe they may have a claim are encouraged to contact an attorney as soon as possible to ensure their rights are preserved.

Have a Breast Mesh Lawyer Review Your Case

Potential lawsuits are now being investigated by breast mesh injury lawyers, who are pursuing caims for women who experienced complications following breast reconstruction or cosmetic augmentation procedures that involved surgical mesh implants.

Free case evaluations are available nationwide to determine whether financial compensation may be available. There are no fees or expenses unless a recovery is obtained in your case.

If you or a loved one required revision or removal surgery due to breast mesh failure, submit your information for review and learn whether you may qualify to pursue a claim.